We are live on ! Find out more
WDA

Wendell David Associates Portfolio holdings

AUM $947M
1-Year Est. Return 10.27%
This Fund
S&P 500
This Quarter Est. Return
+6.46%
1 Year Est. Return
+10.27%
3 Year Est. Return
+45.96%
5 Year Est. Return
+70.2%
10 Year Est. Return
+302.7%
AUM
$885M
AUM Growth
+$41.9M
Cap. Flow
-$4.31M
Cap. Flow %
-0.49%
Top 10 Hldgs %
40.8%
Holding
148
New
2
Increased
28
Reduced
62
Closed
1

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$929K
2
HSY icon
Hershey
HSY
+$677K
3
INTU icon
Intuit
INTU
+$392K
4
ZTS icon
Zoetis
ZTS
+$294K
5
ULTA icon
Ulta Beauty
ULTA
+$255K

Top Sells

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$1.38M
2
DG icon
Dollar General
DG
+$1.24M
3
AAPL icon
Apple
AAPL
+$683K
4
MA icon
Mastercard
MA
+$402K
5
POOL icon
Pool Corp
POOL
+$385K

Sector Composition

Rank Sector Weight
1 Technology 27.52%
2 Healthcare 20.22%
3 Consumer Staples 13.48%
4 Consumer Discretionary 12.34%
5 Financials 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
V icon
51
Visa
V
$684B
$4.44M 0.5%
18,682
+28
+0.2% +$6.41K
HON icon
52
Honeywell
HON
$77B
$4.16M 0.47%
21,272
-16
-0.1% -$2.97K
BDX icon
53
Becton Dickinson
BDX
$45.6B
$4.08M 0.46%
15,444
-515
-3% -$131K
FTV icon
54
Fortive
FTV
$17.9B
$4.05M 0.46%
71,957
+763
+1% +$38.5K
GWW icon
55
W.W. Grainger
GWW
$65.3B
$3.82M 0.43%
4,839
+23
+0.5% +$15.8K
ORLY icon
56
O'Reilly Automotive
ORLY
$72.9B
$3.75M 0.42%
58,905
-270
-0.5% -$16.5K
ZTS icon
57
Zoetis
ZTS
$32.4B
$3.66M 0.41%
21,246
+1,701
+9% +$294K
EW icon
58
Edwards Lifesciences
EW
$49.6B
$3.65M 0.41%
38,745
-15,830
-29% -$1.38M
HSY icon
59
Hershey
HSY
$35.2B
$3.48M 0.39%
13,940
+2,580
+23% +$677K
ULTA icon
60
Ulta Beauty
ULTA
$22B
$3.45M 0.39%
7,330
+520
+8% +$255K
EMR icon
61
Emerson Electric
EMR
$83.9B
$3.22M 0.36%
35,643
-100
-0.3% -$8.42K
DE icon
62
Deere & Co
DE
$160B
$3.21M 0.36%
7,929
– –
DG icon
63
Dollar General
DG
$28B
$3M 0.34%
17,702
-6,270
-26% -$1.24M
UNP icon
64
Union Pacific
UNP
$174B
$2.97M 0.34%
14,501
+41
+0.3% +$8.15K
BCPC
65
Balchem Corp
BCPC
$5.38B
$2.94M 0.33%
21,827
– –
CSCO icon
66
Cisco
CSCO
$457B
$2.93M 0.33%
56,675
-100
-0.2% -$4.92K
ISRG icon
67
Intuitive Surgical
ISRG
$127B
$2.67M 0.3%
7,800
– –
VZ icon
68
Verizon
VZ
$195B
$2.58M 0.29%
69,283
-3,597
-5% -$133K
AMGN icon
69
Amgen
AMGN
$208B
$2.53M 0.29%
11,395
-20
-0.2% -$4.64K
FAST icon
70
Fastenal
FAST
$54.7B
$2.36M 0.27%
80,000
– –
SBUX icon
71
Starbucks
SBUX
$120B
$2.31M 0.26%
23,274
-300
-1% -$31.1K
POOL icon
72
Pool Corp
POOL
$6.75B
$2.21M 0.25%
5,886
-1,125
-16% -$385K
EL icon
73
Estee Lauder
EL
$30.4B
$2.2M 0.25%
11,220
-1,420
-11% -$301K
PFE icon
74
Pfizer
PFE
$143B
$2.11M 0.24%
57,464
-30
-0.1% -$1.17K
EXPD icon
75
Expeditors International
EXPD
$22B
$2.1M 0.24%
17,336
-200
-1% -$22.7K
1 2
3
4 5

Similar funds

IGGA
Iron Gate Global Advisors Nsl, Utah $947M AUM 23.59% 1-Year Est. Return
DG
Discerene Group Stamford, Connecticut $946M AUM 1.38% 1-Year Est. Return
GL
Gemsstock Ltd London, United Kingdom $949M AUM 54.05% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
DCM
Disciplina Capital Management Nashville, Tennessee $944M AUM 10.02% 1-Year Est. Return
CF
Convergence Financial Columbia, Missouri $943M AUM 17.04% 1-Year Est. Return
IC
Inscription Capital Houston, Texas $951M AUM 23.82% 1-Year Est. Return
LEA
Legacy Edge Advisors Syosset, New York $951M AUM

Wendell David Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Wendell David Associates held 148 positions worth $885M, up 5% from $843M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 2%. Wendell David Associates opened 2 new positions and exited 1, leaving the 148-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Wendell David Associates's largest Q2 2023 buy was WEX: 1,102 shares worth $201K.
  • Wendell David Associates added most to Eli Lilly in Q2 2023, an estimated $929K increase.
  • Wendell David Associates's biggest Q2 2023 reduction was Edwards Lifesciences, cutting an estimated $1.38M.
  • Wendell David Associates fully exited US Bancorp in Q2 2023, selling an estimated $221K.
  • Wendell David Associates's ten largest holdings make up 41% of its $885M portfolio in Q2 2023.
  • Wendell David Associates opened 2 new positions and closed 1 in Q2 2023.
  • Wendell David Associates's portfolio value rose 5% quarter-over-quarter to $885M.

Based on Wendell David Associates's 13F filing for Q2 2023, filed 20 Jul 2023.